Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Star Scientific Inc. Stories

2012-06-26 06:24:54

GLEN ALLEN, Va., June 26, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) announced today that the U.S. Patent and Trademark Office ("PTO") has issued Patent No. 8,207,346 (the "346 patent") to the company's wholly owned subsidiary, Rock Creek Pharmaceuticals, Inc. This patent covers an improved method for synthesizing anatabine that facilitates large scale commercial production of high purity anatabine. Anatabine citrate is the active ingredient in Anatabloc®, the...

2012-05-31 06:24:52

GLEN ALLEN, Va., May 31, 2012 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., the manufacturer of Anatabloc® and a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), wishes to extend its congratulations to Fred Couples for being named 2013 U.S. Presidents Cup Captain. Couples, who became a spokesperson and brand ambassador for Anatabloc® in early 2012, was named the U.S. Captain by PGA Tour Commissioner, Tim Finchem, on Tuesday at the Memorial Tournament. The 2013 Presidents Cup...

2012-05-23 06:25:54

GLEN ALLEN, Va., May 23, 2012 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), announced today that it has completed its retail distribution of Anatabloc® at GNC, a leading global specialty retailer of health and wellness products. As of this week, Anatabloc® is now available at all of GNC's corporate stores, which includes approximately 2,922 locations in all fifty states, as well as the District of Columbia and Puerto Rico. The...

2012-05-16 06:26:55

GLEN ALLEN, Va., May 16, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) announced that the U.S. Patent and Trademark Office ("PTO") issued a Notice of Allowance on May 11, 2012 to Rock Creek Pharmaceuticals, Inc., its wholly owned subsidiary, in Application No. 12/729,346, covering an improved method for the synthetic preparation of anatabine. A Notice of Allowance, issued by the PTO, is a notification that an applicant is entitled to a patent. A written patent on this application...

2012-05-10 10:26:20

GLEN ALLEN, Va., May 10, 2012 /PRNewswire/ -- Star Scientific, Inc., (NASDAQ: CIGX) today filed with the Securities Exchange Commission its Form 10-Q for the quarter ended March 31, 2012. The company reported net sales for the quarter ended March 31, 2012 of $1.2 million compared with $156 thousand for the same period in 2011. The increase in net sales during the first quarter of 2012 represents an approximate 700% increase from the same period in 2011 based on increased sales of the...

2012-05-08 06:31:06

GLEN ALLEN, Va., May 8, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) through its wholly owned subsidiary, Rock Creek Pharmaceuticals Inc., announces that it has received important new research findings from its research partner, The Roskamp Institute of Sarasota, Florida. The Institute has completed a successful animal study of nutritional supplementation with Rock Creek's specially formulated anatabine (patent pending), in an animal model of multiple sclerosis. The Roskamp...

2012-04-26 06:25:20

GLEN ALLEN, Va., April 26, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Inc., announces that it has received IRB approval of the first human clinical study of the safety and effects of nutritional supplementation with Anatabloc® in individuals with Alzheimer's disease. The study will be undertaken in conjunction with the Roskamp Institute of Sarasota, Florida, which has been acting as a research partner in...

2012-04-12 06:26:10

GLEN ALLEN, Va., April 12, 2012 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., a wholly owned subsidiary of Star Scientific, Inc., announced that Anatabloc® Unflavored is available as an option on the shopping cart on the Anatabloc® website at https://store.anatabloc.com/products as of today. Anatabloc® Unflavored is a revised formulation containing the same active dietary ingredients in the same dose as our original Anatabloc® product. A significant number of individuals...

2012-04-10 06:28:07

GLEN ALLEN, Va., April 10, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) today announced the appointment of Ms. Talhia T. Tuck as the company's new Vice President for Communications and Investor Relations as of April 18, 2012. Ms. Tuck will assume the position previously held by Ms. Sara T. Machir since 2003. Ms. Tuck has a broad range of media and public relations skills as a result of her prior experiences in TV and print journalism, which started in 2001 when she was a...

2012-04-02 10:25:37

GLEN ALLEN, Va., April 2, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) issued the following comments on the March 30, 2012 FDA Draft Guidance on Harmful and Potentially Harmful Constituents in Tobacco Products under Section 904 of the 2009 Family Smoking Prevention and Tobacco Control Act ("Tobacco Act") and the Summary Report of the Tobacco Products Scientific Advisory Committee ("TPSAC") posted by the FDA on March 21st. (Logo:...